Use of the Electronic Health Record for Monitoring Adverse Drug Reactions

被引：3

作者：

Muzaffar, Anum F. ^{[1
]}

Abdul-Massih, Sandra ^{[2
]}

Stevenson, James M. ^{[2
,4
]}

Alvarez-Arango, Santiago ^{[2
,3
,4
]}

机构：

[1] Johns Hopkins Univ, Sch Med, Dept Pediat, Div Allergy & Immunol, Baltimore, MD 21224 USA

[2] Johns Hopkins Univ, Sch Med, Dept Med, Div Clin Pharmacol, Baltimore, MD 21224 USA

[3] Johns Hopkins Univ, Sch Med, Dept Med, Div Allergy & Clin Immunol, Hopkins Bayview Circle 5501, Baltimore, MD 21224 USA

[4] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21224 USA

来源：

CURRENT ALLERGY AND ASTHMA REPORTS | 2023年 / 23卷 / 07期

关键词：

Drug-related adverse reactions and allergies; Adverse drug reaction documentation; Electronic health records; Drug safety; Pharmacovigilance; Clinical decision support systems; IMPLEMENTATION CONSORTIUM GUIDELINES; PENICILLIN ALLERGY; B GENOTYPE; PHARMACOGENOMICS; DOCUMENTATION; PATIENT; SYSTEMS; PREDICT; CYP2C9;

D O I：

10.1007/s11882-023-01087-w

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

Purpose of ReviewAdverse drug reactions (ADRs) are a significant cause of morbidity and mortality. The electronic health record (EHR) provides an opportunity to monitor ADRs, mainly through the utilization of drug allergy data and pharmacogenomics. This review article explores the current use of the EHR for ADR monitoring and highlights areas that require improvement.Recent FindingsRecent research has identified several issues with using EHR for ADR monitoring. These include the lack of standardization between EHR systems, specificity in data entry options, incomplete and inaccurate documentation, and alert fatigue. These issues can limit the effectiveness of ADR monitoring and compromise patient safety.The EHR has great potential for monitoring ADR but needs significant updates to improve patient safety and optimize care. Future research should concentrate on developing standardized documentation and clinical decision support systems within EHRs. Healthcare professionals should also be educated on the significance of accurate and complete ADR monitoring.

引用

页码：417 / 426

页数：10

共 58 条

[1] Vancomycin Hypersensitivity Reactions Documented in Electronic Health Records [J].

Alvarez-Arango, Santiago ;

Yerneni, Sharmitha ;

Tang, Olive ;

Zhou, Li ;

Mancini, Christian M. ;

Blackley, Suzanne V. ;

Keet, Corinne Allison ;

Blumenthal, Kimberly G. .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2021, 9 (02) :906-912

[2] Adverse drug event reporting systems: a systematic review [J].

Bailey, Chantelle ;

Peddie, David ;

Wickham, Maeve E. ;

Badke, Katherin ;

Small, Serena S. ;

Doyle-Waters, Mary M. ;

Balka, Ellen ;

Hohl, Corinne M. .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 82 (01) :17-29

[3] The FDA's Sentinel Initiative-A Comprehensive Approach to Medical Product Surveillance [J].

Ball, R. ;

Robb, M. ;

Anderson, S. A. ;

Dal Pan, G. .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 99 (03) :265-268

[4] The Use of Electronic Health Records to Study Drug- Induced Hypersensitivity Reactions from 2000 to 2021 A Systematic Review [J].

Bassir, Fatima ;

Varghese, Sheril ;

Wang, Liqin ;

Chin, Yen Po ;

Zhou, Li .

IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2022, 42 (02) :453-497

[5] Evaluating the extent of reusability ofCYP2C19genotype data among patients genotyped for antiplatelet therapy selection [J].

Beitelshees, Amber L. ;

Stevenson, James M. ;

El Rouby, Nihal ;

Dillon, Chrisly ;

Empey, Philip E. ;

Fielstein, Elliot M. ;

Johnson, Julie A. ;

Limdi, Nita A. ;

Ong, Henry H. ;

Franchi, Francesco ;

Angiolillo, Dominick P. ;

Peterson, Joshua F. ;

Rosenman, Marc B. ;

Skaar, Todd C. ;

Tuteja, Sony ;

Cavallari, Larisa H. .

GENETICS IN MEDICINE, 2020, 22 (11) :1898-1902

[6] The Impact of a Reported Penicillin Allergy on Surgical Site Infection Risk [J].

Blumenthal, Kimberly G. ;

Ryan, Erin E. ;

Li, Yu ;

Lee, Hang ;

Kuhlen, James L. ;

Shenoy, Erica S. .

CLINICAL INFECTIOUS DISEASES, 2018, 66 (03) :329-336

[7] Redesigning the allergy module of the electronic health record [J].

Blumenthal, Kimberly G. ;

Park, Miguel A. ;

Macy, Eric M. .

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2016, 117 (02) :126-131

[8] Types of unintended consequences related to computerized provider order entry [J].

Campbell, Emily M. ;

Sittig, Dean F. ;

Ash, Joan S. ;

Guappone, Kenneth P. ;

Dykstra, Richard H. .

JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION, 2006, 13 (05) :547-556

[9] Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and HLA-B Genotypes and Phenytoin Dosing [J].

Caudle, K. E. ;

Rettie, A. E. ;

Whirl-Carrillo, M. ;

Smith, L. H. ;

Mintzer, S. ;

Lee, M. T. M. ;

Klein, T. E. ;

Callaghan, J. T. .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 96 (05) :542-548

[10] Standardization can accelerate the adoption of pharmacogenomics: current status and the path forward [J].

Caudle, Kelly E. ;

Keeling, Nicholas J. ;

Klein, Teri E. ;

Whirl-Carrillo, Michelle ;

Pratt, Victoria M. ;

Hoffman, James M. .

PHARMACOGENOMICS, 2018, 19 (10) :847-860

← 1 2 3 4 5 6 →